Gentofte Hospital is located in Gentofte within Copenhagen in Denmark. Administratively, it is part of the hospital service of Region Hovedstaden. The hospital primarily serves the municipalities of Gentofte, Lyngby-Taarbæk, and Rudersdal, with a population of about 175,000.

During the past decade, Herlev and Gentofte Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herlev and Gentofte Hospital" #1 sponsor was "Herlev and Gentofte Hospital" with 2 trials, followed by "Rigshospitalet, Denmark" with 2 trials sponsored, "University of Minnesota" with 2 trials sponsored, "Biotronik AG" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herlev and Gentofte Hospital" #1 collaborator was "International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Aalborg University Hospital" with 1 trials as a collaborator and "Aarhus University Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Herlev and Gentofte Hospital" are "COVID" (2 trials), "Cognitive Therapy" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Anxiety" (1 trials) and "Anxiety Disorders" (1 trials). Many other conditions were trialed in "Herlev and Gentofte Hospital" in a lesser frequency.

Most popular intervention types in "Herlev and Gentofte Hospital" are "Drug" (4 trials), "Behavioral" (2 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)" (2 trials), "BI 1015550" (1 trials), "Ciprofloxacin" (1 trials) and "Cognitive Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herlev and Gentofte Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Herlev and Gentofte Hospital". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Herlev and Gentofte Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Herlev and Gentofte Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".